View More
Thank you for your interest in CCO content. As a guest, please complete the following information fields. These data help ensure our continued delivery of impactful education.
Become a member (or login)? Member benefits include accreditation certificates, downloadable slides, and decision support tools.
Assistant Professor of Medicine
Division of Pulmonary, Critical Care, & Sleep Medicine
New York University School of Medicine
Director, Medical Intensive Care Unit
Bellevue Hospital
New York, New York
This program has been made available online.
In this presentation, Dr. Sharon Lewin reviews investigational therapies for COVID-19: TMPRSS2 inhibitors, CRISPR-Cas13, and interferon lambda.
Sharon R. Lewin, AO, FRACP, PhD, FAHMS
Released: March 18, 2021
Clinical Care Options (CCO) expert analysis of new data from The IAS COVID-19 Conference: Prevention, 2021, provided by Jens Lundgren, MD, DMSc
Jens D. Lundgren, MD, DMSc
Released: February 24, 2021
Dr. Vikram Mukherjee reviews recent studies on thromboprophylaxis and anticoagulation in persons with COVID-19, from Clinical Care Options (CCO)
Vikramjit Mukherjee, MD
Released: February 19, 2021
Dr. Jens D. Lundgren reviews diagnostic tests for SARS-CoV-2 infection, contrasting antigen tests with nucleic acid assays, and describing how to use and interpret antigen tests from Clinical Care Options (CCO)
Jens D. Lundgren, MD, DMSc
Released: January 29, 2021
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA
Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com
You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.